Radiation and immunotherapy: emerging mechanisms of synergy

Immunotherapy (IO) has become a standard treatment in patients with metastatic and locally advanced non-small cell lung cancer (NSCLC), and is now being tested in patients with early stage disease. IO agents currently in use for lung cancer target PD-1, PD-L1, and CTLA-4. While survival and tumor co...

Descripción completa

Detalles Bibliográficos
Autores principales: Breen, William G., Leventakos, Konstantinos, Dong, Haidong, Merrell, Kenneth W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article on Contemporary Practice in Thoracic Neoplasm Diagnosis, Evaluation and Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711365/
https://www.ncbi.nlm.nih.gov/pubmed/33282406
http://dx.doi.org/10.21037/jtd-2019-cptn-07

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711365/
https://www.ncbi.nlm.nih.gov/pubmed/33282406
http://dx.doi.org/10.21037/jtd-2019-cptn-07

Ejemplares similares